Yahoo
OTC Markets OTCQX - Delayed Quote USD

Vireo Growth Inc. (VREOF)

6.53 -0.15 (-2.25%)
At close: November 6 at 4:00:00 PM EST
VREOF Q3 2026 earnings call
November 10, 2026 at 8 AM EST
Chart Range Bar
Loading chart for VREOF
  • Previous Close 6.68
  • Open 6.67
  • Bid 6.54 x 80000
  • Ask 6.68 x 20000
  • Day's Range 6.50 - 6.69
  • 52 Week Range 6.47 - 21.75
  • Volume 8,822
  • Avg. Volume 50,300
  • Market Cap (intraday) 341.623M
  • Beta (5Y Monthly) 0.18
  • PE Ratio (TTM) --
  • EPS (TTM) -1.70
  • Earnings Date Nov 10, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 45.00
  • Moby Rating Neutral

Vireo Growth Inc. operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah. It sells cannabis products through a network of retail dispensaries and distributors. The company was formerly known as Goodness Growth Holdings, Inc. and changed its name to Vireo Growth Inc. in July 2024. Vireo Growth Inc. was incorporated in 2004 and is headquartered in Minneapolis, Minnesota.

vireogrowth.com

520

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

VREOF
63.72%
S&P/TSX Composite index (^GSPTSE)
12.31%

1-Year Return

VREOF
62.14%
S&P/TSX Composite index (^GSPTSE)
18.89%

3-Year Return

VREOF
11.05%
S&P/TSX Composite index (^GSPTSE)
80.53%

5-Year Return

VREOF
84.00%
S&P/TSX Composite index (^GSPTSE)
66.80%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 209.3M
Earnings -100k
Profit Margin -0.05%

Q2

FY25

Q3

FY25

Q4

FY25

Q2

FY26

0
50M
100M
150M
200M
-0.0%
-0.0%
-0.0%
-0.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

45.00
45.00 Average
6.53 Current
45.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -13.12%

  • Return on Assets (ttm)

    2.28%

  • Return on Equity (ttm)

    -18.88%

  • Revenue (ttm)

    511.67M

  • Net Income Avi to Common (ttm)

    -67.11M

  • Diluted EPS (ttm)

    -1.70

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    104.1M

  • Total Debt/Equity (mrq)

    109.79%

  • Levered Free Cash Flow (ttm)

    -42.95M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: